– Marks M, Marks JL. Viral arthritis. Clin Med (Lond). 2016;16(2):
129–34.
– Holland R, Barnsley L, Barnsley L. Viral arthritis. Aust Fam Physician. 2013;42(11):770–3.
– Laine M, Luukkainen R, Toivanen A. Sindbis viruses and other alphaviruses as cause of human arthritic disease. J Intern Med. 2004;256(6):457–71.
– Harley D, Sleigh A, Ritchie S. Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin Microbiol Rev. 2001;14(4):909–32.
1 Lehmann HW, Knoll A, Kuster RM, Modrow S. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Arthritis Rheum. 2003;48(6):1631–8.
2 Stahl HD, Hubner B, Seidl B, et al. Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis. Ann Rheum Dis. 2000;59(5):342–6.
3 Kappus MR, Sterling RK. Extrahepatic manifestations of acute hepatitis B virus infection. Gastroenterol Hepatol (N Y). 2013;9(2):123–6.
4 Ferri C, Sebastiani M, Antonelli A, Colaci M, Manfredi A, Giuggioli D. Current treatment of hepatitis C-associated rheumatic diseases. Arthritis Res Ther. 2012;14(3):215.
5 European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370–98.
6 Fraser JR, Cunningham AL, Clarris BJ, Aaskov JG, Leach R. Cytology of synovial effusions in epidemic polyarthritis. Aust N Z J Med. 1981;11(2):168–73.
7 Tan LC, Mowat AG, Fazou C, et al. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes. Arthritis Res. 2000;2(2):154–64.
8 Richard JL, Schaetti C, Basler S, Masserey Spicher V. Reduction of acute hepatitis B through vaccina-tion of adolescents with no decrease in chronic hepatitis B due to immigration in a low ende-micity country. Swiss medical weekly. 2017;147:w14409.
9 Witteck A, Schmid P. Hepatitis C – Update 2010. Schweiz Med Forum. 2010;10(42):729–36.
10 Müllhaupt B, Moradpour D. Hepatitis C: Information für Patienten Schweiz Med Forum. 2015;15(17):371–2.
11 Müllhaupt B, Moradpour D. Hepatitis C: Epidemiologie, natürlicher Verlauf und Diagnostik. Schweiz Med Forum. 2015;15(17):360–5.
12 Tarr P, Schmid P, Bernasconi E, Stoeckle M, Kovari H. HIV-Infektion. Schweiz Med Forum. 2015;15(20121):479–85.
13 Stoeckle M. Infektiologie: HIV: Neue Resultate haben Relevanz für Praxis und Public Health Schweiz Med Forum. 2015;15(5051):1179–81.
14 Neumayr A, Stöckle M, Künzli E, et al. Fieber bei Reiserückkehrern. Schweiz Med Forum. 2018;18(16):345–54.
15 Balandraud N, Roudier J. Epstein-Barr virus and rheumatoid arthritis. Joint Bone Spine. 2018;85(2):165–70.
16 Lossius A, Johansen JN, Torkildsen O, Vartdal F, Holmoy T. Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis-association and causation. Viruses. 2012;4(12):3701–30.
17 Karrer U, Nadal D. Epstein-Barr Virus und infektiöse Mononukleose. Schweiz Med Forum. 2014;14(11):226–32.
18 Woolf AD, Campion GV, Chishick A, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med. 1989;149(5):1153–6.
19 Servey JT, Reamy BV, Hodge J. Clinical presentations of parvovirus B19 infection. Am Fam Physician. 2007;75(3):373–6.
20 Crabol Y, Terrier B, Rozenberg F, et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2013;56(7):968–77.
21 Ogawa E, Otaguro S, Murata M, et al. Intravenous immunoglobulin therapy for severe arthritis associated with human parvovirus B19 infection. J Infect Chemother. 2008;14(5):377–82.
22 Smith CA, Petty RE, Tingle AJ. Rubella virus and arthritis. Rheum Dis Clin North Am. 1987;13(2):265–74.
23 Geier DA, Geier MR. Hepatitis B vaccination and arthritic adverse reactions: a followup analysis of the Vaccine Adverse Events Reporting System (VAERS) database. Clin Exp Rheumatol. 2002;20(1):119.
24 Pease C, Keat A. Arthritis as the main or only symptom of hepatitis B infection. Postgrad Med J. 1985;61(716):545–7.
25 Satsangi S, Gupta N. Rheumatologic Manifestations of Viral Hepatitis B and C. Journal of Hepatitis. 2015;1(13):1–5.
26 Kemmer NM, Sherman KE. Hepatitis C-related arthropathy: Diagnostic and treatment considerations. J Musculoskelet Med. 2010;27(9):351–4.
27 Ferri C, Ramos-Casals M, Zignego AL, et al. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmun Rev. 2016;15(12):1145–60.
28 Wener MH, Hutchinson K, Morishima C, Gretch DR. Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia. Arthritis Rheum. 2004;50(7):2305–8.
29 Fox C, Walker-Bone K. Evolving spectrum of HIV-associated rheumatic syndromes. Best Pract Res Clin Rheumatol. 2015;29(2):244–58.
30 Adizie T, Moots RJ, Hodkinson B, French N, Adebajo AO. Inflammatory arthritis in HIV positive patients: A practical guide. BMC Infect Dis. 2016;16:100.
31 Berman A, Espinoza LR, Diaz JD, et al. Rheumatic manifestations of human immunodeficiency virus infection. The American journal of medicine. 1988;85(1):59–64.
32 Berman A, Reboredo G, Spindler A, Lasala ME, Lopez H, Espinoza LR. Rheumatic manifestations in populations at risk for HIV infection: the added effect of HIV. J Rheumatol. 1991;18(10):1564–7.
33 Kole AK, Roy R, Kole DC. Musculoskeletal and rheumatological disorders in HIV infection: Experience in a tertiary referral center. Indian J Sex Transm Dis 2013;34(2):107–12.
34 Braun DL, Kouyos RD, Balmer B, Grube C, Weber R, Gunthard HF. Frequency and Spectrum of Unexpected Clinical Manifestations of Primary HIV-1 Infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2015;61(6):1013–21.
35 Guerin B, Arfi S, Numeric P, et al. Polyarthritis in HTLV-1-infected patients. A review of 17 cases. Rev Rhum Engl Ed. 1995;62(1):21–8.
36 Suhrbier A, Jaffar-Bandjee MC, Gasque P. Arthritogenic alphaviruses--an overview. Nat Rev Rheumatol. 2012;8(7):420–9.
37 Mossong J, Hens N, Friederichs V, et al. Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect. 2008;136(8):1059–68.
38 Rohrer C, Gartner B, Sauerbrei A, et al. Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect 2008;136(11):1564–75.
39 Office fédéral de la santé publique (OFSP). Epidémiologie rubéole. Available at: https://www.bag.admin.ch/bag/fr/home/service/zahlen-fakten/zahlen-zu-infektionskrankheiten.exturl.html/aHR0cDovL3d3dy5iYWctYW53LmFkbWluLmNoLzIwMTZfbWVsZG/VzeXN0ZW1lL2luZnJlcG9ydGluZy9kYXRlbmRldGFpbHMvZi9y/b2V0ZWxuLmh0bWw_d2ViZ3JhYj1pZ25vcmU=.html.
40 Compendium Suisse des Médicaments. MMR. Available at:
https://compendium.ch/mpro/mnr/27623/html/fr.
41 Hsu HH, Feinstone SM, Houfnagle JH. Acute viral hepatitis. In: Fourth Edition MG, Bennett JE, Dolin R (Eds). Mandell, Douglas, and Bennett’s Principles and Practices of Infectious Diseases, New York: Churchill Livingstone. 2016.
42 Richard JL, Schaetti C, Basler S, Mausezahl M. The epidemiology of hepatitis C in Switzerland: trends in notifications, 1988–2015. Swiss medical weekly. 2018;148:14619.
43 Rosner I, Rozenbaum M, Toubi E, Kessel A, Naschitz JE, Zuckerman E. The case for hepatitis C arthritis. Semin Arthritis Rheum. 2004;33(6):375–87.
44 Blum JA, Hatz CF. Dengue- und Chikungunya-Fieber in der Allgemeinpraxis. Schweiz Med Forum. 2009;9(35):610–14.
45 Oliver M, Grandadam M, Marimoutou C, et al. Persisting mixed cryoglobulinemia in Chikungunya infection. PLoS Negl Trop Dis. 2009;3(2):e374.
46 Kuno G. A Re-Examination of the History of Etiologic Confusion between Dengue and Chikungunya. PLoS Negl Trop Dis. 2015;9(11):e0004101.
47 Bahlmann AS, Theilacker C, Hirsch HH. Update Zikavirus Schweiz Med Forum. 2016; 16(3031):600–4.
48 Duffy MR, Chen TH, Hancock WT, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. The New England journal of medicine. 2009;360(24):2536–43.
49 Harley D, Sleigh A, Ritchie S. Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clinical microbiology reviews. 2001;14(4):909–32, table of contents.
50 Soden M, Vasudevan H, Roberts B, et al. Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection. Arthritis Rheum. 2000;43(2):365–9.
51 Hueston L, Toi CS, Jeoffreys N, Sorrell T, Gilbert G. Diagnosis of Barmah Forest virus infection by a nested real-time SYBR green RT-PCR assay. PLoS One 2013;8(7):e65197.
52 Rezza G, Chen R, Weaver SC. O’nyong-nyong fever: a neglected mosquito-borne viral disease. Pathog Glob Health. 2017;111(6):271–5.
53 Neumayr A, Gabriel M, Fritz J, et al. Mayaro virus infection in traveler returning from Amazon Basin, northern Peru. Emerg Infect Dis 2012; 18(4): 695–6.